Advanced Clinical Trial Centre (ACTC)

Built for the safe delivery of complex clinical trials

Australia's only accredited private hospital dedicated to clinical trials, supporting sponsors with experienced investigators, purpose-built infrastructure and integrated study delivery from feasibility through to study close-out.

Why Sponsors Partner with ACTC

The Advanced Clinical Trial Centre (ACTC) combines dedicated clinical trial infrastructure, experienced investigators and integrated operational teams to support complex clinical research from feasibility through to close-out.

Proven Clinical Trial Delivery

Built for Sponsor Confidence

Quality

Validated eSource and eReg platform Remote monitoring capability Audit-ready quality systems

  • Validated eSource and eReg platform
  • Remote monitoring capability
  • Audit-ready quality systems

Safety

Validated eSource and eReg platform Remote monitoring capability Audit-ready quality systems

  • Access to SCGH Medical Emergency Team support
  • Dedicated clinical research facility
  • Purpose-built early phase infrastructure

Research Collaboration

Validated eSource and eReg platform Remote monitoring capability Audit-ready quality systems

  • Located within the QEII Medical Precinct
  • Connected to leading hospitals, research institutes and specialist services 

Capability Across Complex Clinical Research

ACTC supports early and later phase clinical trials across cancer and general medicine, with dedicated infrastructure for complex protocol delivery.

Therapeutic Areas

Oncology

Clinical trial delivery across solid tumour studies, including complex early phase and later phase protocols.

Haematology

Experience supporting studies in haematological malignancies and emerging therapeutic approaches.

General Medicine

A rapidly growing therapeutic area supported by dedicated clinical infrastructure and the capability to deliver early and later phase studies across multiple disease areas.

Advanced Therapies

Capability to support complex investigational products, including cell and gene therapy studies where study requirements align with ACTC infrastructure and clinical model.

ACTC provides coordinated support across the full clinical trial lifecycle:

  1. Feasibility and protocol assessment
  2. Study start-up and activation
  3. Recruitment and participant access
  4. Clinical delivery
  5. Data and monitoring
  6. Study close-out and reporting

Integrated Study Delivery

Frequently Asked by Sponsors

What types of studies does ACTC support?

ACTC supports early and later phase clinical trials across oncology, haematology, general medicine and selected advanced therapy programs. 

ACTC typically achieves a 6-8 week pathway from study award to activation.

Yes. ACTC operates validated electronic systems and supports remote monitoring capabilities.

ACTC was established specifically to support complex clinical research through dedicated infrastructure, experienced investigators and integrated operational teams.

Let's Discuss Your Next Study

Whether you're evaluating a new program, exploring Australian site options or expanding an existing portfolio, our team can provide rapid feasibility assessment and study start-up support.

Contact Business Development

Email: [email protected]
Phone: +61 8 6382 5100